Sustained release pharmaceutical formulation

Details Sustained release pharmaceutical formulation Sustained release pharmaceutical formulation

1980-06-19

1982-02-23

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

424 35, A61K 950

Patent

active

043168841

ABSTRACT:
It has been found that indoprofen can be used in increased safety at its effective anti-inflammatory dose in humans and that the activity of indoprofen is greatly prolonged by microencapsulating microparticles of indoprofen in a solid protective coating of a cellulose ether such as ethylcellulose.

REFERENCES:
patent: 3155590 (1964-11-01), Miller et al.
patent: 3341416 (1967-09-01), Anderson et al.
patent: 3488418 (1970-01-01), Holliday et al.
patent: 3922338 (1975-11-01), Estevenel et al.
Chem. Abstr. 87 #141233m (1977), 86 #150629(b) #8593s (1977), 82 #106135f (1975), 82 #118718m (1975), 80 #10382s (1974).
De Sabata, V. Chem. Abstr. 87 #157026g (1977) of Drugs Pharm. Sci., 1976(3)(Micro-encapsulation), 143-161, "Bioavailability from Microencapsulated Drugs".
Bakan, J. Chem. Abstr. 84 #126673z (1976) of Polym. Sci. Technol., 1975(8) (Polym. Med. Surg.): 213-235, "Microcapsule Drug Delivery Systems".
Chem. Abstracts Index "Capsules", vol. 66 (1967) and vol. 89 (1978) "Microcapsule" entries.

Affiliated with

Also associated with

Rating

Sustained release pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release pharmaceutical formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1774114